Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection.

Sci Rep 2016 Apr 11;6:23992. Epub 2016 Apr 11.

Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Recent studies have demonstrated a potential link between circulating cell-free mitochondrial DNA (mtDNA) content and cancers. However, there is no study evaluating the association between circulating mtDNA as a non-invasive marker of hepatocellular carcinoma (HCC) risk. We conducted a nested case-control study to determine circulating mtDNA content in serum samples from 116 HBV-related HCC cases and 232 frequency-matched cancer-free HBV controls, and evaluate the retrospective association between mtDNA content and HCC risk using logistic regression and their temporal relationship using a mixed effects model. HCC cases had significantly lower circulating mtDNA content than controls (1.06 versus 2.47, P = 1.7 × 10(-5)). Compared to HBV patients with higher mtDNA content, those with lower mtDNA content had a significantly increased risk of HCC with an odds ratio (OR) of 2.19 (95% confidence interval [CI] 1.28-3.72, P = 0.004). Quartile analyses revealed a significant dose-dependent effect (Ptrend = 0.001) for this association. In a pilot longitudinal sub-cohort of 14 matched cases-control pairs, we observed a trend of dramatically decreased mtDNA content in cases and slightly decreased mtDNA content in controls, with a significant interaction of case-control status with time (Pinteraction = 0.049). Our findings suggest that circulating mtDNA is a potential novel non-invasive biomarker of HCC risk in HBV patients.

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep23992DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827061PMC
April 2016
9 Reads

Publication Analysis

Top Keywords

mtdna content
32
circulating mtdna
16
hcc risk
12
mtdna
10
content
9
hcc cases
8
hepatocellular carcinoma
8
content controls
8
mitochondrial dna
8
decreased mtdna
8
hbv patients
8
hcc
6
risk
5
circulating
5
higher mtdna
4
compared hbv
4
patients higher
4
content lower
4
content increased
4
odds ratio
4

References

(Supplied by CrossRef)
Article in CA Cancer J Clin.
A Jemal et al.
CA Cancer J Clin. 2011
Article in Hepatology.
WR Kim et al.
Hepatology. 2009
Article in Eur J Cancer.
X Fu et al.
Eur J Cancer. 2012
Article in Nat Rev Cancer.
WH Koppenol et al.
Nat Rev Cancer. 2011
Article in Nat Rev Genet.
XJ Chen et al.
Nat Rev Genet. 2005
Article in Environ Mol Mutagen.
DC Wallace et al.
Environ Mol Mutagen. 2010
Article in Mitochondrion.
NB Larsen et al.
Mitochondrion. 2005
Article in Nat Rev Genet.
RW Taylor et al.
Nat Rev Genet. 2005
Article in Mutat Res.
HC Lee et al.
Mutat Res. 2004
Article in Br J Cancer.
PH Yin et al.
Br J Cancer. 2004
Article in Eur J Surg Oncol.
S Yamada et al.
Eur J Surg Oncol. 2006

Similar Publications